Generate evidence to inform policy change and scale up access to hepatitis C diagnosis and treatment.
current phase of drug development
updated 29 Feb 2020
In July 2018, DNDi and diagnostic product development and delivery partnership FIND announced a partnership, in collaboration with the Ministry of Health in Malaysia, to generate evidence to support policy change and scale up HCV diagnosis and treatment.
As a part of the project, simplified decentralized screening for HCV was initiated in Malaysia. People who screen positive and are subsequently confirmed to have HCV were linked to treatment either in government hospitals or, on a voluntary basis, as part of the DNDi clinical trial.
News & publications
- Treatment coverage and drug expenditure in hepatitis C patients from 2013 to 2019: A journey of improving treatment accessibility in Malaysia through government-led initiatives
- 17 July 2019 – Nationwide hepatitis C screening campaign initiated by the Malaysian Ministry of Health
- 23 July 2018 – FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
Get our latest news, personal stories, research articles, and job opportunities.